Chemoinformaics analysis of 1,3-Naphthalenediol
| Molecular Weight | 160.172 | nRot | 0 |
| Heavy Atom Molecular Weight | 152.108 | nRig | 11 |
| Exact Molecular Weight | 160.052 | nRing | 2 |
| Solubility: LogS | -2.357 | nHRing | 0 |
| Solubility: LogP | 2.406 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 2 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 11 |
| nHA | 2 | APOL | 23.6383 |
| nHD | 2 | BPOL | 8.02566 |
| QED | 0.62 |
| Synth | 1.79 |
| Natural Product Likeliness | 0.912 |
| NR-PPAR-gamma | 0.015 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.009 |
| Pgp-sub | 0.005 |
| HIA | 0.051 |
| CACO-2 | -4.582 |
| MDCK | 0.0000166 |
| BBB | 0.08 |
| PPB | 0.919132 |
| VDSS | 0.766 |
| FU | 0.0616049 |
| CYP1A2-inh | 0.985 |
| CYP1A2-sub | 0.428 |
| CYP2c19-inh | 0.354 |
| CYP2c19-sub | 0.079 |
| CYP2c9-inh | 0.278 |
| CYP2c9-sub | 0.904 |
| CYP2d6-inh | 0.783 |
| CYP2d6-sub | 0.855 |
| CYP3a4-inh | 0.397 |
| CYP3a4-sub | 0.153 |
| CL | 15.364 |
| T12 | 0.886 |
| hERG | 0.027 |
| Ames | 0.714 |
| ROA | 0.646 |
| SkinSen | 0.948 |
| Carcinogencity | 0.611 |
| EI | 0.991 |
| Respiratory | 0.827 |
| NR-Aromatase | 0.129 |
| Antiviral | No |
| Prediction | 0.745935 |